Product Information
Open The Door To Market For Women's Health Products And Successfully Create Many Well-Known Star Brands
Ipratropium Bromide Inhalation Solution
Generic Name：
Ipratropium Bromide Inhalation Solution
Indications：
Ipratropium bromide inhalation Solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
Dosage Forms and Strengths
Inhalation Solution: 0.5 mg/2 mL
- Description
-
Generic Name：Ipratropium Bromide Inhalation Solution
Indications：Ipratropium bromide inhalation Solution administered either alone or with other bronchodilators, especially beta adrenergics, is indicated as a bronchodilator for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
Dosage Forms and Strengths：Inhalation Solution: 0.5 mg/2 mL
Dosage and Administration：
Maintenance: The usual dosage of ipratropium bromide inhalation solution is 500 mcg (1 Unit-Dose Vial) administered three to four times a day by oral nebulization, with doses 6 to 8 hours apart.
Acute Exacerbation: One single-dose vial per administration; repeat dosing can be done until patient condition stabilizes. Dosing interval to be determined by the physician.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.